Nath Bio Genes India Share Price
Sector: Crops
259.10 +3.75 (1.47%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
257.6
Today’s High
264.5
52 Week Low
167.5
52 Week High
263.05
259.20 +4.08 (1.60%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
257.82
Today’s High
264.31
52 Week Low
167.15
52 Week High
263
Key Metrics
- Market Cap (In Cr) 484.83
- Beta 1.87
- Div. Yield (%) 0.78
- P/B 0.79
- TTM P/E 8.31
- Peg Ratio 1.44
- Sector P/E 26.16
- D/E 0.18
- Open Price 264.5
- Prev Close 255.35
Nath Bio Genes India Analysis
Price Analysis
-
1 Week20.29%
-
3 Months33.26%
-
6 Month18.91%
-
YTD23.01%
-
1 Year17.78%
Risk Meter
- 44% Low risk
- 44% Moderate risk
- 44% Balanced Risk
- 44% High risk
- 44% Extreme risk
Nath Bio Genes India News
Nath Bio Genes India Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 332.62
- Selling/ General/ Admin Expenses Total
- 121.25
- Depreciation/ Amortization
- 3.26
- Other Operating Expenses Total
- 27.31
- Total Operating Expense
- 285.4
- Operating Income
- 47.23
- Net Income Before Taxes
- 38.12
- Net Income
- 39.62
- Diluted Normalized EPS
- 19.31
- Period
- 2024
- Total Assets
- 880.23
- Total Liabilities
- 270.31
- Total Equity
- 609.92
- Tangible Book Valueper Share Common Eq
- 316.31
- Period
- 2024
- Cashfrom Operating Activities
- 80.5
- Cashfrom Investing Activities
- -27.4
- Cashfrom Financing Activities
- -13.68
- Net Changein Cash
- 39.41
- Period
- 2023
- Total Revenue
- 301.36
- Selling/ General/ Admin Expenses Total
- 35.3
- Depreciation/ Amortization
- 3.01
- Other Operating Expenses Total
- 102.43
- Total Operating Expense
- 255.63
- Operating Income
- 45.73
- Net Income Before Taxes
- 36.16
- Net Income
- 35.01
- Diluted Normalized EPS
- 18.42
- Period
- 2023
- Total Assets
- 792.8
- Total Liabilities
- 219.62
- Total Equity
- 573.17
- Tangible Book Valueper Share Common Eq
- 296.12
- Period
- 2023
- Cashfrom Operating Activities
- 38.37
- Cashfrom Investing Activities
- -2.88
- Cashfrom Financing Activities
- -1.67
- Net Changein Cash
- 33.81
- Period
- 2022
- Total Revenue
- 278.36
- Selling/ General/ Admin Expenses Total
- 60.54
- Depreciation/ Amortization
- 3.08
- Other Operating Expenses Total
- 56.52
- Total Operating Expense
- 332.99
- Operating Income
- -54.63
- Net Income Before Taxes
- -63.39
- Net Income
- -67.34
- Diluted Normalized EPS
- -5.07
- Period
- 2022
- Total Assets
- 741.91
- Total Liabilities
- 199.94
- Total Equity
- 541.97
- Tangible Book Valueper Share Common Eq
- 278.86
- Period
- 2022
- Cashfrom Operating Activities
- 17.04
- Cashfrom Investing Activities
- -19.87
- Cashfrom Financing Activities
- -22.23
- Net Changein Cash
- -25.05
- Period
- 2021
- Total Revenue
- 307.56
- Selling/ General/ Admin Expenses Total
- 58.1
- Depreciation/ Amortization
- 2.82
- Other Operating Expenses Total
- 47.44
- Total Operating Expense
- 243.54
- Operating Income
- 64.02
- Net Income Before Taxes
- 56.75
- Net Income
- 55.66
- Diluted Normalized EPS
- 29.28
- Period
- 2021
- Total Assets
- 789.51
- Total Liabilities
- 176.23
- Total Equity
- 613.28
- Tangible Book Valueper Share Common Eq
- 315.54
- Period
- 2021
- Cashfrom Operating Activities
- 1.11
- Cashfrom Investing Activities
- -10.28
- Cashfrom Financing Activities
- 16.4
- Net Changein Cash
- 7.23
- Period
- 2020
- Total Revenue
- 279.89
- Selling/ General/ Admin Expenses Total
- 49.98
- Depreciation/ Amortization
- 1.45
- Other Operating Expenses Total
- 47.79
- Total Operating Expense
- 226.66
- Operating Income
- 53.23
- Net Income Before Taxes
- 48.51
- Net Income
- 50.48
- Diluted Normalized EPS
- 26.52
- Period
- 2020
- Total Assets
- 729.95
- Total Liabilities
- 172.33
- Total Equity
- 557.62
- Tangible Book Valueper Share Common Eq
- 285.44
- Period
- 2020
- Cashfrom Operating Activities
- 9.47
- Cashfrom Investing Activities
- -14.44
- Cashfrom Financing Activities
- 5.56
- Net Changein Cash
- 0.6
- Period
- 2019
- Total Revenue
- 230.93
- Selling/ General/ Admin Expenses Total
- 41.71
- Depreciation/ Amortization
- 1.45
- Other Operating Expenses Total
- 38.1
- Total Operating Expense
- 189.13
- Operating Income
- 41.8
- Net Income Before Taxes
- 38.87
- Net Income
- 38.43
- Diluted Normalized EPS
- 20.22
- Period
- 2019
- Total Assets
- 646.06
- Total Liabilities
- 138.48
- Total Equity
- 507.58
- Tangible Book Valueper Share Common Eq
- 265.2
- Period
- 2019
- Cashfrom Operating Activities
- -22.94
- Cashfrom Investing Activities
- -20.48
- Cashfrom Financing Activities
- 20.14
- Net Changein Cash
- -23.28
- Period
- 2024-03-31
- Total Revenue
- 43.04
- Selling/ General/ Admin Expenses Total
- 33.75
- Depreciation/ Amortization
- 0.98
- Other Operating Expenses Total
- 14.01
- Total Operating Expense
- 39.68
- Operating Income
- 3.36
- Net Income Before Taxes
- 2.28
- Net Income
- 2.62
- Diluted Normalized EPS
- 0.81
- Period
- 2024-03-31
- Total Assets
- 880.23
- Total Liabilities
- 270.31
- Total Equity
- 609.92
- Tangible Book Valueper Share Common Eq
- 316.31
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 80.5
- Cashfrom Investing Activities
- -27.4
- Cashfrom Financing Activities
- -13.68
- Net Changein Cash
- 39.41
- Period
- 2023-12-31
- Total Revenue
- 31.74
- Selling/ General/ Admin Expenses Total
- 7.97
- Depreciation/ Amortization
- 0.76
- Other Operating Expenses Total
- 3.98
- Total Operating Expense
- 26.85
- Operating Income
- 4.89
- Net Income Before Taxes
- 2.09
- Net Income
- 3.82
- Diluted Normalized EPS
- 0.69
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 22.57
- Selling/ General/ Admin Expenses Total
- 9.44
- Depreciation/ Amortization
- 0.76
- Other Operating Expenses Total
- 3.81
- Total Operating Expense
- 18.24
- Operating Income
- 4.32
- Net Income Before Taxes
- 1.95
- Net Income
- 1.6
- Diluted Normalized EPS
- 0.84
- Period
- 2023-09-30
- Total Assets
- 846.75
- Total Liabilities
- 242.71
- Total Equity
- 604.05
- Tangible Book Valueper Share Common Eq
- 312.8
- Period
- 2023-09-30
- Cashfrom Operating Activities
- -20.36
- Cashfrom Investing Activities
- -0.48
- Cashfrom Financing Activities
- -1.5
- Net Changein Cash
- -22.34
- Period
- 2023-06-30
- Total Revenue
- 235.28
- Selling/ General/ Admin Expenses Total
- 70.09
- Depreciation/ Amortization
- 0.76
- Other Operating Expenses Total
- 5.31
- Total Operating Expense
- 198.91
- Operating Income
- 36.37
- Net Income Before Taxes
- 33.72
- Net Income
- 33.5
- Diluted Normalized EPS
- 17.53
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 44.99
- Selling/ General/ Admin Expenses Total
- 6.12
- Depreciation/ Amortization
- 0.99
- Other Operating Expenses Total
- 65.08
- Total Operating Expense
- 42.04
- Operating Income
- 2.94
- Net Income Before Taxes
- 1.67
- Net Income
- 1.44
- Diluted Normalized EPS
- 0.76
- Period
- 2023-03-31
- Total Assets
- 792.8
- Total Liabilities
- 219.62
- Total Equity
- 573.17
- Tangible Book Valueper Share Common Eq
- 296.12
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 38.37
- Cashfrom Investing Activities
- -2.88
- Cashfrom Financing Activities
- -1.67
- Net Changein Cash
- 33.81
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Nath Bio Genes India Technical
Moving Average
SMA
- 5 Day251.85
- 10 Day233.2
- 20 Day217.69
- 50 Day202.94
- 100 Day201.45
- 300 Day203.26
Nath Bio Genes India Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Sakuma Exports
- 32.04
- 0.13
- 0.41
- 39.15
- 13.21
- 754.24
- Axita Cotton
- 21.44
- -0.02
- -0.09
- 35.39
- 19.02
- 559.32
- Nath Bio Genes India
- 259.1
- 3.75
- 1.47
- 263.05
- 167.5
- 492.39
- Harrisons Malayalam
- 219.5
- -0.25
- -0.11
- 226
- 129.1
- 405.1
- Tierra Agrotech
- 59.75
- 3.05
- 5.38
- 186.27
- 50.44
- 391.92
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Sakuma Exports
- 19.81
- 1.53
- 6.7
- 1.04
- Axita Cotton
- 27.15
- 8.67
- 33.51
- 1.59
- Nath Bio Genes India
- 13.35
- 0.8
- 3.87
- 7.33
- Harrisons Malayalam
- -
- 2.82
- 13.89
- 3.64
- Tierra Agrotech
- -
- 3.81
- -31.83
- -16.22
Nath Bio Genes India Shareholding
Shareholding Pattern
*Promoter pledging: 7.47%
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 08-May-24
- Audited Results & Final Dividend
- 18-Jan-24
- Quarterly Results
- 16-Oct-23
- Quarterly Results
- 10-Aug-23
- Quarterly Results
- 22-Apr-23
- Audited Results & Final Dividend
- 14-Feb-23
- Quarterly Results
- 20-Oct-22
- Quarterly Results
- 13-Aug-22
- Quarterly Results
- 30-May-22
- Audited Results, Dividend & A.G.M.
- 11-Feb-22
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 11-Jul-23
- 23-May-23
- AGM
- 30-Jun-23
- 24-Apr-23
- AGM
- 27-Aug-21
- 24-Jun-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 24-Apr-23
- -
- 04-Jul-23
- 2
- 30-May-22
- -
- 23-Jun-22
- 2
- 24-Jun-21
- -
- 18-Aug-21
- 2
![No data](https://www.livemint.com/lm-img/dev/null-data.png)
![No data](https://www.livemint.com/lm-img/dev/null-data.png)
![No data](https://www.livemint.com/lm-img/dev/null-data.png)